News

• Entasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
  13:30 - GlobeNewswire
•  
• Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
  11/12/2019 / 14:00 - GlobeNewswire
•  
• Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
  11/09/2019 / 14:02 - GlobeNewswire
•  
• Merck says Q3 sales jump 12% YoY to $12.4B
  10/29/2019 / 11:49 - TeleTrader
•  
• Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer in Podium and Poster Presentations at the Fifth International Cancer lmmunotherapy Conference in Paris, France
  09/27/2019 / 12:05 - GlobeNewswire
•  
• Merck Grant to Support Smithsonian Future Exhibition on History of American Medicine
  09/03/2019 / 16:08 - GlobeNewswire
•  
• Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update
  08/14/2019 / 14:30 - GlobeNewswire
•  
• Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer
  08/13/2019 / 14:05 - GlobeNewswire
•  
• Vaccinex Announces $13.8 Million Private Placement
  07/31/2019 / 13:30 - GlobeNewswire
•  
• Merck&Co reports EPS of $1.03 in Q2, up 63% YoY
  07/30/2019 / 12:48 - TeleTrader
•  
• Merck mulling more M&A - reports
  06/19/2019 / 12:20 - TeleTrader
•  
• Merck's lung cancer treatment receives FDA approval
  06/18/2019 / 13:10 - TeleTrader
•  
• IBM, KPMG, Merck, and Walmart work on drug blockchain
  06/13/2019 / 15:56 - TeleTrader
•  
• Merck to acquire Tilos Therapeutics for up to $773M
  06/10/2019 / 13:42 - TeleTrader
•  
• Vaccinex Presents Updated Interim Results from a Phase 1b/2 Study of Pepinemab in Combination with Avelumab in Non-Small Cell Lung Cancer at the 2019 ASCO Annual Meeting
  06/03/2019 / 14:00 - GlobeNewswire